Literature DB >> 32572032

Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis.

Chao Liang1,2,3, Jie Li4, Cheng Lu1,2,3,5, Duoli Xie1,2,3, Jin Liu1,2,3, Chuanxin Zhong1,2,3, Xiaohao Wu1,2,3, Rongchen Dai1,2,3, Huarui Zhang1,2,3, Daogang Guan1,2,3, Baosheng Guo1,2,3, Bing He1,2,3, Fangfei Li1,2,3, Xiaojuan He1,2,3,5, Wandong Zhang6, Bao-Ting Zhang4, Ge Zhang7,8,9, Aiping Lu1,2,3,10.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32572032      PMCID： PMC7308310          DOI： 10.1038/s41467-020-16901-6

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


Correction to: Nature Communications 10.1038/s41467-019-12163-z, published online 8 October 2019. This Article contained errors in Figs. 4i and 5a, for which the authors apologise. The lanes labelled ARNT (lower row) in Fig. 4i and HIF1alpha in Fig. 5a were not from the membranes used to probe for the other proteins shown in each panel. These have now been replaced with the correct rows from the same membranes. These errors were reproduced in the source data file that contains the uncropped membranes. The errors did not affect the conclusions of the manuscript. They have now been corrected both the PDF and HTML versions of the Article, and the Source Data file has been amended to include the correct images of the respective uncropped membranes.
  1 in total

Review 1.  Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology.

Authors:  Dima W Alhamad; Husam Bensreti; Jennifer Dorn; William D Hill; Mark W Hamrick; Meghan E McGee-Lawrence
Journal:  J Mol Endocrinol       Date:  2022-08-22       Impact factor: 4.869
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.